(Q41579438)

4 October 2017

1 reference

title

Thymus therapy for cancer? A criteria-based, systematic review (English)

1 reference

4 October 2017

Ernst E

1

1 reference

4 October 2017

publication date

1 April 1997

1 reference

European Journal of Cancer

4 October 2017

published in

1 reference

4 October 2017

volume

33

1 reference

4 October 2017

issue

4

1 reference

4 October 2017

page(s)

531-535

1 reference

Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment

4 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900475-3

7 January 2021

Contemporary unorthodox treatments in cancer medicine. A study of patients, treatments, and practitioners

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900475-3

7 January 2021

Complementary cancer treatments: hope or hazard?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900475-3

7 January 2021

Thymic hormonal activity on human peripheral blood lymphocytes, in vitro. V. Effect on induction of lymphocytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900475-3

7 January 2021

Thymosin fraction V and intensive combination chemotherapy. Prolonging the survival of patients with small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900475-3

7 January 2021

A randomized trial to evaluate the immunorestorative properties of thymostimulin in patients with Hodgkin's disease in complete remission

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900475-3

7 January 2021

Effects of thymostimulin with combination chemotherapy in patients with aggressive non-Hodgkin's lymphoma. A report from the Italian Lymphoma Study Group (GISL).

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900475-3

7 January 2021

Severe anaphylactic reaction to thymostimulin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900475-3

7 January 2021

Effect of treatment with thymustimulin (Tp-1) on T and B cells in lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900475-3

7 January 2021

Depressed monocyte polarization and clustering of dendritic cells in patients with head and neck cancer: in vitro restoration of this immunosuppression by thymic hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900475-3

7 January 2021

Thymostimulin enhances the natural cytotoxic activity of patients with transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900475-3

7 January 2021

Modulation of natural killer activity by thymosin alpha 1 and interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900475-3

7 January 2021

10.1016/S0959-8049(96)00475-3

Identifiers

DOI

1 reference

release_msitf6jnavf2reialtsd6s3h2u

4 October 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/msitf6jnavf2reialtsd6s3h2u

24 November 2022

mapped directly with Wikidata item

1 reference